258 related articles for article (PubMed ID: 2786616)
1. Clinical presentation of Graves' ophthalmopathy.
Wiersinga WM; Smit T; van der Gaag R; Mourits M; Koornneef L
Ophthalmic Res; 1989; 21(2):73-82. PubMed ID: 2786616
[TBL] [Abstract][Full Text] [Related]
2. Intravenous immunoglobulin versus corticosteroid in treatment of Graves' ophthalmopathy.
Baschieri L; Antonelli A; Nardi S; Alberti B; Lepri A; Canapicchi R; Fallahi P
Thyroid; 1997 Aug; 7(4):579-85. PubMed ID: 9292946
[TBL] [Abstract][Full Text] [Related]
3. Temporal relationship between onset of Graves' ophthalmopathy and onset of thyroidal Graves' disease.
Wiersinga WM; Smit T; van der Gaag R; Koornneef L
J Endocrinol Invest; 1988 Sep; 11(8):615-9. PubMed ID: 2907524
[TBL] [Abstract][Full Text] [Related]
4. Untreated Graves' disease patients without clinical ophthalmopathy demonstrate a high frequency of extraocular muscle (EOM) enlargement by magnetic resonance.
Villadolid MC; Yokoyama N; Izumi M; Nishikawa T; Kimura H; Ashizawa K; Kiriyama T; Uetani M; Nagataki S
J Clin Endocrinol Metab; 1995 Sep; 80(9):2830-3. PubMed ID: 7673432
[TBL] [Abstract][Full Text] [Related]
5. Thyroid-associated ophthalmopathy in Iranian patients.
Kashkouli MB; Jam S; Sabzvari D; Ketabi N; Azarinia S; SeyedAlinaghi S; Mofid A
Acta Med Iran; 2011; 49(9):612-8. PubMed ID: 22052145
[TBL] [Abstract][Full Text] [Related]
6. Effect of abnormal thyroid function on the severity of Graves' ophthalmopathy.
Prummel MF; Wiersinga WM; Mourits MP; Koornneef L; Berghout A; van der Gaag R
Arch Intern Med; 1990 May; 150(5):1098-101. PubMed ID: 1691908
[TBL] [Abstract][Full Text] [Related]
7. Graves' ophthalmopathy. A clinical and immunologic review.
Sergott RC; Glaser JS
Surv Ophthalmol; 1981; 26(1):1-21. PubMed ID: 6895125
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic criteria for Graves' ophthalmopathy.
Bartley GB; Gorman CA
Am J Ophthalmol; 1995 Jun; 119(6):792-5. PubMed ID: 7785696
[TBL] [Abstract][Full Text] [Related]
9. The use of real-time orbital ultrasound in Graves' ophthalmopathy: a comparison with computed tomography.
Given-Wilson R; Pope RM; Michell MJ; Cannon R; McGregor AM
Br J Radiol; 1989 Aug; 62(740):705-9. PubMed ID: 2670033
[TBL] [Abstract][Full Text] [Related]
10. Appearance of Graves' disease on orbital computed tomography.
Enzmann DR; Donaldson SS; Kriss JP
J Comput Assist Tomogr; 1979 Dec; 3(6):815-9. PubMed ID: 583152
[TBL] [Abstract][Full Text] [Related]
11. Serum antibodies against the flavoprotein subunit of succinate dehydrogenase are sensitive markers of eye muscle autoimmunity in patients with Graves' hyperthyroidism.
Gunji K; De Bellis A; Kubota S; Swanson J; Wengrowicz S; Cochran B; Ackrell BA; Salvi M; Bellastella A; Bizzarro A; Sinisi AA; Wall JR
J Clin Endocrinol Metab; 1999 Apr; 84(4):1255-62. PubMed ID: 10199764
[TBL] [Abstract][Full Text] [Related]
12. Orbital lymphoma masquerading as thyroid ophthalmopathy.
Boyce PJ
J Am Optom Assoc; 1998 Oct; 69(10):666-73. PubMed ID: 9805448
[TBL] [Abstract][Full Text] [Related]
13. [Graves' ophthalmopathy--a prospective clinical study].
Bogdănici C; Marcu C
Oftalmologia; 1999; 48(3):19-22, 25. PubMed ID: 10641113
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of increased intraocular pressure in Graves' disease--evidence of frequent subclinical ophthalmopathy.
Gamblin GT; Harper DG; Galentine P; Buck DR; Chernow B; Eil C
N Engl J Med; 1983 Feb; 308(8):420-4. PubMed ID: 6687400
[TBL] [Abstract][Full Text] [Related]
15. Antibodies targeting the calcium binding skeletal muscle protein calsequestrin are specific markers of ophthalmopathy and sensitive indicators of ocular myopathy in patients with Graves' disease.
Gopinath B; Musselman R; Beard N; El-Kaissi S; Tani J; Adams CL; Wall JR
Clin Exp Immunol; 2006 Jul; 145(1):56-62. PubMed ID: 16792674
[TBL] [Abstract][Full Text] [Related]
16. Graves' thyroid ophthalmopathy in Ethiopian patients.
Teshome T; Seyoum B
Ethiop Med J; 2001 Jan; 39(1):1-8. PubMed ID: 11338463
[TBL] [Abstract][Full Text] [Related]
17. Carotid cavernous fistula in a patient with Graves' ophthalmopathy.
Loré F; Polito E; Cerase A; Bracco S; Loffredo A; Pichierri P; Talidis F
J Clin Endocrinol Metab; 2003 Aug; 88(8):3487-90. PubMed ID: 12915622
[TBL] [Abstract][Full Text] [Related]
18. Graves' ophthalmopathy: V. Aetiology of upper eyelid retraction in Graves' ophthalmopathy.
Feldon SE; Levin L
Br J Ophthalmol; 1990 Aug; 74(8):484-5. PubMed ID: 2390525
[TBL] [Abstract][Full Text] [Related]
19. Cloning and characterization of the novel thyroid and eye muscle shared protein G2s: autoantibodies against G2s are closely associated with ophthalmopathy in patients with Graves' hyperthyroidism.
Gunji K; De Bellis A; Li AW; Yamada M; Kubota S; Ackrell B; Wengrowicz S; Bellastella A; Bizzarro A; Sinisi A; Wall JR
J Clin Endocrinol Metab; 2000 Apr; 85(4):1641-7. PubMed ID: 10770210
[TBL] [Abstract][Full Text] [Related]
20. Orbital radiotherapy combined with high dose systemic glucocorticoids for Graves' ophthalmopathy is more effective than radiotherapy alone: results of a prospective randomized study.
Marcocci C; Bartalena L; Bogazzi F; Bruno-Bossio G; Lepri A; Pinchera A
J Endocrinol Invest; 1991 Nov; 14(10):853-60. PubMed ID: 1802923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
